Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

NCT00107263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

558

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Osteoporosis

Interventions

DRUG: letrozole
DRUG: zoledronic acid

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]